Trump is also expected to speak about potentially loosening restrictions on marijuana in the U.S. If cannabis is classified ...

The deal adds some of the biggest names in drug manufacturing to the president's "most favored nation" pricing plan.

Trump signed an executive order reclassifying marijuana as a less dangerous drug. The change could help the industry without ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

Cannabis industry observers believe it is increasingly likely that President Donald Trump will soon sign an executive order ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

The Trump administration introduced Tuesday a new drug pricing model that seeks to allow Medicare Part D plans and state Medicaid agencies to cover GLP-1s, potentially expanding coverage for the ...

In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug policy that ...